Gatifloxacin

英文名： Gatifloxacin

别名：加替沙星;1-环丙基-6-氟-1,4-二氢-8-甲氧基-7-(3-甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸;1-环丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氢-4-氧-喹啉-3-羧酸;加替沙星片;4-甲基-3-硝基苯硼酸频哪醇酯;加替沙星标准品;加替沙星杂质;金阳碱;加替沙星,盐酸D4;加替沙星·3;加替沙星(标准品);加替沙星溶液,100PPM;加替沙星/1-环丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氢-4-氧-喹啉-3-羧酸;优质高纯度，加替沙星原粉;加替沙星(分析标准品) 加替沙星;1-环丙基-6-氟-1,4-二氢-8-甲氧基-7-(3-甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸;1-环丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氢-4-氧-喹啉-3-羧酸;加替沙星片;4-甲基-3-硝基苯硼酸频哪醇酯;加替沙星标准品;加替沙星杂质;金阳碱;加替沙星,盐酸D4;加替沙星·3;加替沙星(标准品);加替沙星溶液,100PPM;加替沙星/1-环丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氢-4-氧-喹啉-3-羧酸;优质高纯度，加替沙星原粉;加替沙星(分析标准品) 展开

CAS No. : 112811-59-3

分子式 : C₁₉H₂₂FN₃O₄

分子量 : 375.39

大包装询价? 收藏产品

中文名称	Gatifloxacin
中文别名	加替沙星;1-环丙基-6-氟-1,4-二氢-8-甲氧基-7-(3-甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸;1-环丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氢-4-氧-喹啉-3-羧酸;加替沙星片;4-甲基-3-硝基苯硼酸频哪醇酯;加替沙星标准品;加替沙星杂质;金阳碱;加替沙星,盐酸D4;加替沙星·3;加替沙星(标准品);加替沙星溶液,100PPM;加替沙星/1-环丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氢-4-氧-喹啉-3-羧酸;优质高纯度，加替沙星原粉;加替沙星(分析标准品)
英文名称	Gatifloxacin
英文别名	1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid;GATIFLOXACIN;1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-(3-METHYLPIPERAZIN-1-YL)-4-OXO-3-QUINOLINECARBOXYLIC ACID;1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDROXY-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-3-QUINOLINECARBOXYLIC ACID;1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-PIPERAZIN-1-YL)-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID;AKOS NCG1-0010;TEQUIN;Gatifloxacin(AM-1155);Gatifloxacin n-Hydrate;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid);2H2O;AM 1155;AM-1155;BMS 206584-01;PD 135432;PD-135432;Zymar;CG5501;Gatiquin;BMS-206584;GASTRODINUM;Gatifloxacin API;Gatifloxacin 1.5H20;Gatiflo;Gatifloxacine;Gatispan;Zymaxid;Gatilox;Gaity;CG 5501;Gatifloxacin [USAN:INN];gatifloxacin anhydrous;gatifloxacinum;gatifloxacino;1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo;Gatifloxacin hydrate;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-o;Gatifloxacin 100 microg/mL in Acetonitrile;Spectrum3_000999;C19H22FN3O4.1.5H2O;CS-1841;NS00004983;CAS-112811-59-3;BRD-A74980173-001-06-9;MLS006011836;HMS2093G06;BMS-20658401;SPECTRUM1504272;NSC 758701;Gatifloxacin Sesquihydrate,(S);Spectrum2_000487;HMS3259P06;HMS3372J10;HMS3372J12;1-cyclopropyl-6-fluoro-8-methoxy-7-;DB01044;Gatifloxacin, Antibiotic for Culture Media Use Only;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid;DTXSID5045704;FT-0631189;HMS3715N03;Kinome_3137;Pharmakon1600-01504272;Zymer (TN);Spectrum4_001127;CHEMBL31;AB00171654_17;Gatifloxacin (sesquihydrate);1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic a;1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid;AM-1155 (Sesquihydrate);MLS000759493;CCG-39529;Tox21_110984_1;HMS2090K10;D08011;KBioGR_001613;81485Y3A9A;HMS1922J15;BCP13408;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid;GATIFLOXACIN [WHO-DD];UNII-81485Y3A9A;SR-01000610458-2;BMS-206584-01;SY070194;KBio3_001917;Spectrum_001909;C07661;KBio2_002442;SCHEMBL22591;NCGC00068236-05;HY-10581;BDBM50117914;Z1824566854;Bonoq;Spectrum5_001468;SR-01000610458-3;SMR000043336;s1340;AB00171654-13;NCGC00178525-01;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;CG-5501;NC00702;AMY17781;BRD-A74980173-001-02-8;HB3263;NSC758701;FT-0626635;AKOS004119932;GATIFLOXACIN [MI];NCGC00068236-06;AC-1944;1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid;112811-59-3;160738-57-8;RKL10068;(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methox...
CAS No.	112811-59-3
分子式	C₁₉H₂₂FN₃O₄
分子量	375.39

象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group

搜索质检报告(COA)

搜索MSDS

相关产品